SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5 | +25.0% | 170 | +11.1% | 0.00% | – |
Q2 2023 | $4 | 0.0% | 153 | +41.7% | 0.00% | – |
Q1 2023 | $4 | -20.0% | 108 | -19.4% | 0.00% | – |
Q4 2022 | $5 | -99.9% | 134 | 0.0% | 0.00% | – |
Q3 2022 | $5,000 | +25.0% | 134 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 134 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -20.0% | 134 | -15.7% | 0.00% | – |
Q4 2021 | $5,000 | -28.6% | 159 | -45.0% | 0.00% | – |
Q4 2020 | $7,000 | -12.5% | 289 | +5.1% | 0.00% | – |
Q3 2019 | $8,000 | – | 275 | – | 0.00% | – |
Q2 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2018 | $183,000 | -33.9% | 5,500 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $277,000 | -27.7% | 5,500 | -14.1% | 0.00% | 0.0% |
Q2 2018 | $383,000 | -35.2% | 6,400 | -83.5% | 0.00% | -66.7% |
Q1 2016 | $591,000 | -79.6% | 38,723 | -82.0% | 0.00% | -81.2% |
Q4 2015 | $2,892,000 | +16.7% | 215,147 | +21.8% | 0.02% | +14.3% |
Q3 2015 | $2,478,000 | +864.2% | 176,635 | +1068.2% | 0.01% | +1300.0% |
Q2 2015 | $257,000 | – | 15,120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |